LBF20107PG09: Difference between revisions
No edit summary |
No edit summary |
||
(19 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR1735 | |LipidBank=XPR1735 | ||
|LipidMaps=LMFA03010053 | |LipidMaps=LMFA03010053 | ||
|SysName= 1,11alpha,15S- | |SysName=(1,11alpha,15S) -Trihydroxy-prost-trans-13-en-9-one | ||
|Common Name=&&Prostaglandin E1 Alcohol | |Common Name=&&Prostaglandin E_1 alcohol&&(1,11alpha,15S) -Trihydroxy-prost-13(E)-en-9-one&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=Prostaglandin E1 Alcohol shows bronchodialational effect on human respiratory tract muscle.[[Reference:Nizankowska_E:Sheridan_AQ:Maile_MH:Cross_CJ:Nizankowski_R:Prochowska_K:Szczeklik_A:,Prostaglandins,1985,29,349|{{RelationTable/GetFirstAuthor|Reference:Nizankowska_E:Sheridan_AQ:Maile_MH:Cross_CJ:Nizankowski_R:Prochowska_K:Szczeklik_A:,Prostaglandins,1985,29,349}}]]Prostaglandin E1 Alcohol shows agnoist effects selectively for EP2 and EP4.[[Reference:De_Vries_GW:Guarino_P:McLaughlin_A:Chen_J:Andrews_S:Woodward_DF:,Br. J. Pharmacol.,1995,115,1231|{{RelationTable/GetFirstAuthor|Reference:De_Vries_GW:Guarino_P:McLaughlin_A:Chen_J:Andrews_S:Woodward_DF:,Br. J. Pharmacol.,1995,115,1231}}]]Prostaglandin E1 Alcohol inhibits M-CSF synthesis by bone marrow stromal cells.[[Reference:Besse_A:Trimoreau_F:Faucher_JL:Praloran_V:Denizot_Y:,Biochim. Biophys. Acta,1999,1450,444|{{RelationTable/GetFirstAuthor|Reference:Besse_A:Trimoreau_F:Faucher_JL:Praloran_V:Denizot_Y:,Biochim. Biophys. Acta,1999,1450,444}}]] | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 17:04, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1735 |
LipidMaps | LMFA03010053 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20107PG09 |
Prostaglandin E1 alcohol | |
---|---|
![]() | |
Structural Information | |
(1,11α,15S) -Trihydroxy-prost-trans-13-en-9-one | |
| |
Formula | C20H36O4 |
Exact Mass | 340.26135963999997 |
Average Mass | 340.49744 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CCCCCCCO)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
Prostaglandin E1 Alcohol shows bronchodialational effect on human respiratory tract muscle. Nizankowska_E et al.Prostaglandin E1 Alcohol shows agnoist effects selectively for EP2 and EP4. De_Vries_GW et al.Prostaglandin E1 Alcohol inhibits M-CSF synthesis by bone marrow stromal cells. Besse_A et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
[hide]Reported Metabolites, References | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|